Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

246 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-18

Study Completion Date

2024-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the sensitivity, specificity, and accuracy of the Resistell Phenotech device in testing antibiotic susceptibility of Gram-negative bacteria (i.e., E. coli or K. pneumoniae) to clinically relevant antibiotics. The study is designed as a prospective, non-interventional, multi-center, single-arm study.

The blood culture samples from bacteremia patients that are positive for E. coli or K. pneumoniae will be tested with the Resistell Phenotech device after strain identification by MALDI-TOF. The results of the Resistell AST will be compared with the results from the disk diffusion tests (all sites use the Kirby-Bauer disk diffusion test), and site dependent tests (VITEK® 2, BD Phoenix™, MicroScan WalkAway system, and/or EUCAST RAST), which are currently the standard AST methods in the microbiology laboratories at the participating sites.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis

NCT05002413

Bacteremia Sepsis

COMPLETED

Clinical Impact of Fast Phenotypic Antimicrobial Susceptibility Testing on Patients With Gram-Negative Rod Bacteremia

NCT03745014

Gram-negative Bacteremia

WITHDRAWN NA

Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections

NCT02060513

Infection Skin and Subcutaneous Tissue Bacterial Infections Healthcare-associated Infection +1 more

COMPLETED

Clinical Impact of Rapid AST Directly From Blood Cultures

NCT03992703

Bacterial Infections

COMPLETED

Rapid Antimicrobial Susceptibility Testing with MIC Directly from Positive Blood Cultures with ASTar

NCT06218277

Bacteremia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bacteremia Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resistell Phenotech

Resistell Phenotech IVD device used to assess susceptibility of Gram negative bacteria to antibiotics.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have signed a General Consent form approving use of their residual blood samples for research purposes (applicable at CHUV only)
* Patients who have signed a consent allowing the use of their residual sample (Restprobenerklärung) (applicable at MUI, only)
* Patients over the age of 18 years (\>18)
* Patients with bacteremia considered to be due to E. coli or K. pneumoniae
* Patients whose positive blood cultures were not older than 24 hours at the time of AST start

Exclusion Criteria

* Patients with documented refusal of the use of biological material for research purposes (applicable at CHUV, only)
* Patients with polymicrobial bacteremia

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No